English | 简体中文 | 繁體中文 | 한국어 Home | About us | Services | Partners | Events | Contact us | Login Saturday, March 07, 2026  Simp. Chinese Press Releases Language: All English Indonesian Japanese Korean Thai Trad. Chinese Simp. Chinese Vietnamese  Medicine Clinical Trials Agilex Biolabs与Endpoints新闻合作开展消卷积炎症和免疫学临床试验 May 21, 2021 13:00 HKT Agilex Biolabs祝贺Bionomics Limited BNC210 PK上的结果 Apr 30, 2021 14:00 HKT Agilex Biolabs收购领先的Biolab TetraQ作为APAC扩展计划的一部分 Apr 07, 2021 15:00 HKT 新标准的设立将为整个亚太地区提供最佳的骨质疏松症医疗管理 Jan 28, 2021 01:30 HKT AIM ImmunoTech宣布其药物Ampligen的ME/CFS临床试验已开始接受COVID-19长期患者的注册 Dec 24, 2020 21:00 HKT << Previous  Next >>  Releases By Industry Business ASEAN Daily News Government HR Local Biz SMEs Startups Trade Show Communications Advertising Broadcast, Film & Sat Media & Marketing Telecoms Wireless & Mobility CryptoCurrency Blockchain Technology Crypto, Exchange ICO Metaverse, Games Mining & Staking NFTs Financial Banking & Insurance Cards & Payments Daily Finance Exchanges & Software FinTech Funds & Equities Legal & Compliance Venture Capital & PE Real Estate & REIT Trade Finance Industrial Aerospace & Defence Airlines Automotive Chemical General Construct, Engineering Cosmetics, Spec.Chem Food & Beverages Manufacturing Marine & Offshore Metals & Mining Oil & Gas Print & Package Transport & Logistics Lifestyle Design & Art Beauty & Skin Care Boating Education Gaming Fashion & Apparel Hospitality Motorsports Regional, Lifestyle Retail & eCommerce Sports Travel & Tourism Watches & Jewelry Medicine Alternative BioTech Clinical Trials Healthcare & Pharm MedTech Sustainablity Agritech Alternative Energy Energy Environment, ESG EVs, Transportation Smart Cities Water Technology Artificial Intel [AI] Automation [IoT] CyberSecurity Datacenter & Cloud Digital World Electronics Engineering Enterprise IT Materials & Nanotech Copyright © 2026 ACN Newswire - Asia Corporate News Network Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575 Connect With us: